TY - CHAP M1 - Book, Section TI - Margetuximab-cmkb (Margenza) Approved for Treatment of Metastatic HER2-Positive Breast Cancer A1 - Peh, Keng Hee A1 - Kolesar, Jill M. PY - 2020 T2 - PPP Updates AB - SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/29 UR - ppp.mhmedical.com/updatesContent.aspx?gbosid=556586 ER -